A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.

ABSTRACT:

SUBMITTER: Niu P 

PROVIDER: S-EPMC7089443 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature